Document:

Form of Fee Per Procedure Lease Agreement

 Exhibit 10.15 
  
 TECHNOLOGY LICENSE AGREEMENT 
  

This Fee Per Procedure Agreement (“Agreement”) is made as of the      day of
                     2004 by and between Sound Surgical Technologies LLC, a Colorado limited liability company (“SST” or
“we” or “us”) with offices at 357 So. McCaslin Blvd., Suite 100, Louisville, CO 80027-2932, facsimile 303-926-8615, phone 303-926-8608, e-mail sstmail@soundsurgical.com and
____________________________________________________________________________________(“User” or “you” or “your”) with offices at ________________________________________________________________ 
  
 We grant to you and you accept from us a technology license on the following terms and
conditions: 
  
 1. LICENSE OF EQUIPMENT. 
  
 We grant to you and you accept from us a nonexclusive, nontransferable license (the
“License”) for the technology embodied in the equipment checked on Schedule I incorporated in this Agreement (the “Equipment”) that we will provide to you. 
  
 License Term; Renewal; Early Termination. This Agreement begins on the date we deliver the Equipment to you (the “Effective
Date”) and will continue through the last day of the 36th full calendar month following the month
(“Acceptance Month”) in which you sign and deliver to us our Acceptance of Equipment form (attached). You agree to sign and deliver that form to us before using the Equipment for procedures other than training procedures done with our
representative. We reserve the right to terminate this Agreement as to all or any portion of the Equipment if the cumulative number of monthly procedures performed with the Equipment during any three month period is below 12. 
  
 2. FEES. You agree to pay us a fee of
$         per procedure performed with the Equipment during the term of this Agreement, plus applicable taxes, when each payment is due. We will advise you as to (a) the due date of each Fee payment, and (b)
the address to which you must send your Fee payments. Fees are due whether or not you receive an invoice from us. Unless a proper exemption certificate is provided, applicable sales and use taxes will be added to the Fees. For any payment that we do
not receive by its due date, you agree to pay a late charge equal to the higher of 10% of the amount due or $25.00 (not to exceed the maximum amount permitted by law), as reasonable collection costs. You agree that we can, but do not have to, take
on your behalf any action that you fail to take as required by this Agreement, and our expenses will be deemed additional Fees that you owe us. To the extent allowed by law, any late payment or non-payment of any past due amount will accrue interest
at the lower of 18% per annum or the highest legal rate from the due date until paid. If we take legal action to collect amounts due to us under this Agreement, you agree to pay all of our costs and expenses of collection, including reasonable
attorneys fees. 
  
 3. PROCEDURES; REPORTING; AUDIT RIGHTS. 
  
 Procedure. A procedure is a single surgical event on a single patient, but may
include surgical attention to multiple body sites during such single surgical event.  
  
 Reporting. You will report to us by facsimile sent to 303-926-8615 or by e-mail to sstmail@soundsurgical.com (or such other facsimile number or e-mail address that we may specify in a notice to you) each
Monday the number of VASER® procedures performed,
and the date and type of each such procedure, since the last report (or since the delivery of the Equipment for the first such report). We may establish a different method of reporting, and you agree to cooperate in making such reports as we
reasonably may request. 
  
 Audit Rights. Upon our request our
representatives may inspect your books and records at any time(s) during your regular business hours, at the place where they are kept, to verify the number of procedures performed with the Equipment. We will comply with applicable law regarding
patient confidentiality in making such inspections. If such inspection determines that you have inaccurately reported the number of procedures for more than one month, we will have the right to charge you, and you agree to pay, for each unreported
procedure a fee up to 3 times the per procedure fee specified in this Agreement, or for the cost of such inspection, or both such fee and such cost. 
  
 4. TAXES. You are solely responsible for all taxes of any kind, including sales, use, property and other taxes imposed by any federal, state or local government on
the transactions contemplated by this Agreement and on the Equipment, excluding only taxes based on our net income. You will pay us, when invoiced, all taxes (including any sales, use and personal property taxes) relating to this Agreement and the
Equipment. 
  
 5. TRAINING AND MARKETING SUPPORT. We will provide you at no
cost 1 training day for physician VASER-certification training and staff in-service training. Additional training/in-service days may be provided at a cost of $(***) per day. In addition, we will provide VASER-certified physicians and one of your
staff representatives admittance to VASER user meetings. We will provide you with marketing support including a didactic CD; marketing materials as they become available from us; and the use (subject to our approval of the manner of use) of the
VASER logo and “VASER-certified” label, provided that you maintain at your facility at all times at least one responsible representative who has completed required VASER certification training. 
  
 6. YOUR RIGHTS AND OBLIGATIONS REGARDING THE EQUIPMENT. 
  
 Location. The License entitles you to possess and use the Equipment at the address
for you given above. You agree not to remove the Equipment or allow the Equipment to be removed from that location without our prior written permission, which we will not withhold unreasonably. 

 Use of Equipment. The VASER® Amplifier may be used only by a licensed and VASER®-certified physician in a surgical setting appropriate for the procedure to be performed in compliance with all applicable laws and regulations. You are responsible for ensuring compliance with this
requirement and for determining the fitness and suitability of the Equipment for any particular use, including without limitation use in surgery in general or in any surgical procedure in particular. You assume all risk of use or misuse of the
Equipment and agree to save, indemnify and hold us harmless from any injuries to your patients treated with the Equipment, except injuries resulting directly and solely from the failure of the Equipment to perform in accordance with
manufacturer’s specifications. 
  
 Care; Notice of Damage or Failure.
You are responsible for protecting the Equipment from loss or damage of any kind. You agree to follow the instructions and advice contained in the User’s Guide(s) delivered to you with the Equipment. You will notify us immediately of any damage
to or loss of any of the Equipment and of any failure of the Equipment to operate properly. 
  
 Insurance. You will obtain and maintain in place at your sole expense during the term of this Agreement (a) professional liability insurance and (b) comprehensive property and casualty insurance covering the
Equipment against loss and damage from all usual perils in an agreed value amount of US$(***). All such insurance shall be primary to any insurance carried by us and shall name us an additional insured and as loss payee with respect to loss or
damage of the Equipment. You will deliver to us upon request a certificate of insurance from your carrier evidencing such coverage. 
  
 Confidentiality. You acknowledge that much of the technology embodied in the Equipment is proprietary and confidential to SST. No persons other than our authorized
representatives are to open the VASER® Amplifier, the VentXTM Console, the PFMS, or a VASER Fragmentation Handpiece for any purpose. There are no user-serviceable parts inside the Equipment. You will not allow anyone not regularly in your employ or who is not a medical
professional who regularly assists you in medical procedures to test or use the Equipment for any purpose without our prior written consent, except that if you first notify us of your intent to do so, you may allow any licensed and
VASER®-certified physician to use the Equipment in providing medical care to a patient. 
  
 Access. You will grant our representatives’ access to the Equipment during normal business hours at our request for purposes of inspection, replacement, and field maintenance and upgrades, if any.

  
 Return of Equipment Upon Termination. Upon termination of the license
for any reason, you will deliver to us at our address under this Agreement, transportation prepaid, within 5 days after the date of termination of the License, all of the Equipment in good working condition (unless we, in our good faith judgment,
determine that the fact that the Equipment is not in good working condition is not due to any fault or failure on your part or is due to a loss covered by your insurance). 
  
 7. PAYMENT. 
  
 Payments Due. All payments are due and payable to us in U.S. Dollars at our address under this Agreement (or such other address for payment as we may notify to
you. All payments are due on or before the 5th day after the date of our invoice to you (the “Due Date”).

  
 Late Payment; Collection. If you fail to make any payment within 10
days after the Due Date, you agree that we may terminate the License upon 5 days prior notice to you and that we may enter the premises where the Equipment is located and remove the same at any time during normal business hours. You agree to pay the
costs to remove the Equipment and return it to our principal facility. If we take action to collect amounts due to us under this Agreement, you agree to pay all our costs of collection, including reasonable attorney’s fees. 
  
 8. OWNERSHIP; NO LIENS; LIMITED WARRANTY. 
  
 Ownership; No Liens. We retain at all times sole and exclusive ownership of all
right, title and interest in and to the Equipment and the technology and inventions it embodies, except only the rights granted to you in this Agreement. We also retain sole and exclusive ownership of all modifications and upgrades to the Equipment,
even if you suggest or specifically describe such modification or upgrade to us. We will affix to the Equipment a label stating that the Equipment is owned by us. You agree that you will not remove, cover or deface that label, and that you will not
represent to any person or entity that you have any right, title or interest in or to the Equipment, except the right to possess and use the Equipment pursuant to this Agreement. You will not create or allow to be created by anyone (other than by
us) any lien or encumbrance of any kind on the Equipment, and you agree to save, indemnify and hold us harmless from and against any loss or damage to us by any such lien or encumbrance (other than those we may create), including without limitation
the reasonable costs and expenses of removing the same. You agree to sign and deliver to us upon request one or more financing statements (for example Form UCC-1) as we deem desirable to secure and protect our interest in the Equipment. 

 
 Limited Warranty. During the warranty period stated below, we will repair or
replace the Equipment at our expense, provided that we determine, in our sole judgment, that the Equipment failure was due to misuse, neglect or accident, or that it has been repaired, altered or tampered with in any way by any person other than our
authorized representative, or that it has been used with any ultrasonic power generator, suction or irrigation system, hand piece, probe or foot switch, as the case may be, other than those provided by us for use with the Equipment, you will be
responsible for all shipping and related costs, as well as the costs of repair or replacement. You must follow the return procedures specified in the appropriate User’s Guide. Warranty period; VASER Amplifier, VentX Console, Precision Fluid
Management System - one year; fragmentation hand piece - 6 months for defective materials or workmanship; VASER probes, VentX Cannulae - 90 days for defective materials or workmanship. We warrant that we have good title to the Equipment delivered to
you, that we have the right to license to you the technology contained in the Equipment, and that the Equipment and the technology in it do not infringe the valid intellectual property rights of any third party. 

 EXCLUSION OF OTHER WARRANTIES 
  
 Except for the limited warranties stated above, we make no warranty, express or implied, including without limitation any warranty of
merchantability or fitness of the Equipment for any particular purpose. You are solely responsible for determining the suitability of the Equipment, singly or in combination, for any particular use or procedure. 
  
 Purchase of Ancillary Items. You are responsible for purchasing separately all other
items necessary for use of the Equipment and not supplied with it, including, but not limited to, skin ports and disposables such as tubing and canisters. 
  
 Responsibility for Loss or Damage. You are responsible for any loss of or damage to the Equipment from any cause whatsoever. You agree to read and follow the
instructions and advice contained in the User’s Guide(s) delivered to you with the Equipment. You will notify us immediately of any damage to or loss of any of the Equipment and of any failure of the Equipment to operate properly. In the event
of loss or damage to the Equipment, you will pay us the amount we customarily charge to repair or replace the Equipment (the decision to repair or replace the Equipment is at our sole option). If you have satisfied your obligations under this
Paragraph, we will forward to you any insurance proceeds that we receive for lost, damaged, or destroyed Equipment. If you are in default, we will apply any insurance proceeds we receive to reduce your obligations under this Agreement. 

 
 9. LIMITATION OF LIABILITY. 
  
 Our liability for failure of the Equipment to operate correctly or at all is limited to
repair or replacement of the Equipment, at our sole discretion. We will not be liable for any other losses, damages, costs or expenses resulting directly or indirectly from failure of the Equipment to operate correctly or at all. Our liability for
breach of any warranty made above or for any breach of this Agreement is limited to the aggregate payments received by us in the twelve (12) months immediately preceding the breach giving rise to such liability. In no event will we be liable for
indirect, incidental or consequential damages, including without limitation your loss of income or costs of postponed or cancelled procedures In no event will we be liable for indirect, incidental or consequential damages, including without
limitation your loss of income or costs of postponed or canceled procedures. 
  
 10. DEFAULT. You will be in default under this Agreement if any of the following happens: (a) we do not receive any Fees or other payment due under this Agreement within 10 days after its due date, or (b) you or any of your
guarantors become insolvent, are liquidated, dissolve, merge, transfer substantially all stock or assets, stop doing business, or assign rights or property for the benefit of creditors, or (c) a petition is filed by or against you or any of your
guarantors under any bankruptcy or insolvency law, or (d) (for individuals) you or any of your guarantors die, or have a guardian appointed, or (e) any representation you have made in this Agreement shall prove to be false or misleading in any
material aspect, or (f) you or any of your guarantors breach the terms of any guaranty and do not correct the default within 10 days after we send you written notice of the default, or (g) you default on any other agreement between you and us (or
our affiliates). 
  
 11. REMEDIES. Upon the occurrence of default,
we may, in our sole discretion, do any or all of the following: (a) provide written notice to you of default, (b) collect all payments then due and (c) terminate this Agreement. We have the right to require you to make the Equipment available to us
for repossession during reasonable business hours or we may repossess the Equipment, so long as we do not breach the peace in doing so, or we may use legal process in compliance with applicable law pursuant to court order to have the Equipment
repossessed. You will not make any claims against us or the Equipment for trespass, damage or any other reason. We will retain all of our rights against you even if we do not choose to enforce them at the time of your default. 
  
 12. NOTICE. 
  
 Notices under this Agreement shall be in writing sent by facsimile, e-mail, recognized national courier service, or U.S. Postal Service mail
to the facsimile number, e-mail, or street address given for the addressee at the beginning of this Agreement. You and we may change our respective facsimile, e-mail and street addresses by notice to the other. Notices will be effective when sent in
accordance with this paragraph, provided that notices sent by e-mail will be effective upon electronic delivery to the sender of a delivery receipt. 
  
 13. ASSIGNMENT. 
  
 You may not assign this Agreement without our prior written consent. 
  
 14. GOVERNING LAW. 
  
 This Agreement
shall be governed in all respects by the laws of the state of Colorado, excluding the choice or conflicts of law provisions of such laws. 
  
 15. EFFECT OF TERMINATION. 
  
 The provisions of Sections 2,3,4,6 (until all Equipment is returned to us), and 7 - 11 of this Agreement and any payment obligations incurred prior to the effective date
of termination of this Agreement shall survive any termination of this Agreement for so long as necessary to carry out the intent of those provisions. 

 By signing below, you and we acknowledge your and our acceptance of and agreement with all of the terms and conditions in
this Agreement. 
  

			
	  

	 	Sound Surgical Technologies LLC
	 Licensee [Print name of Licensee]
	 	 

  

							
				
	 By
	 	  

	 	By	 	  

				
	 Print Name
	 	  

	 	Print Name	 	  

				
	 Title
	 	  

	 	Title	 	  

				
	 Date
	 	  

	 	Date	 	  

  
 Schedule I 
 Equipment: 
  

			
	VASER® Amplifier	  	Serial No.
	VentXTM Console	  	Serial No.
	Precision Fluid Management System	  	Serial No.
	VASER® Fragmentation Handpiece	  	Serial No.
	VASER® Probes	  	Quantity
	VASER® Probes	  	Quantity
	VentXTM Handles/Cannulae	  	Quantity
	Sterilization Trays	  	Quantity
	Sound SurgicalTM Skin Ports	  	Quantity
	Skin Port Tool	  	Quantity2004 Long-Term Incentive and Equity Award Plan

 EXHIBIT 4.10 
  
 YELLOW ROADWAY CORPORATION 
 2004 LONG-TERM INCENTIVE AND EQUITY AWARD PLAN 
  

  
 Exhibit 4.10

  
 YELLOW ROADWAY CORPORATION 
 2004 LONG-TERM INCENTIVE AND EQUITY AWARD PLAN 
  
 1. Definitions. In this Plan, except where the context otherwise indicates, the following definitions shall apply: 
  
 1.1 “Affiliate” means a corporation,
partnership, business trust, limited liability company, or other form of business organization at least a majority of the total combined voting power of all classes of stock or other equity interests of which is owned by the Company, either directly
or indirectly. 
  
 1.2
“Agreement” means a written agreement or other document evidencing an Award that shall be in such form as the Committee may specify. The Committee in its discretion may, but need not, require a Participant to sign an Agreement.

  
 1.3 “Automatic Adjustment
Event” means a change in the outstanding Common Stock by reason of a stock dividend, stock split, or reverse stock split. 
  
 1.4 “Award” means a grant of: 
  

(a) an Option; 
  
 (b) a SAR; 
  
 (c) Restricted Stock; 
  
 (d) a Restricted Stock Unit; 
  
 (e) a Performance Award; or 
  
 (f) an Other Stock-Based Award. 
  
 1.5 “Board” means the Board of Directors of the Company. 
  
 1.6 “Code” means the Internal Revenue Code of 1986, as amended. 
  
 1.7 “Committee” means the committee(s),
subcommittee(s), or person(s) the Board appoints to administer this Plan or to make or administer specific Awards hereunder. If no appointment is in effect at any time, “Committee” means the Compensation Committee of the Board.
Notwithstanding the foregoing, “Committee” means the Board for purposes of granting Awards to Non-Employee Directors and administering this Plan with respect to those Awards, unless the Board determines otherwise. 
  
 1.8 “Common Stock” means the Company’s
common stock, par value $1.00 per share. 
  
 1.9
“Company” means Yellow Roadway Corporation and any successor thereto. 
  
 1.10 “Date of Exercise” means the date on which the Company receives notice of the exercise of an Option or SAR in
accordance with the terms of Section 8. 
  
 1.11
“Date of Grant” means the date on which an Award is granted under this Plan. 
  
 1.12 “Eligible Person” means any person who is: 
  
 (a) an Employee; 
  

(b) hired to be an Employee; 
  
 (c) a Non-Employee Director; or 
  
 (d) a consultant or independent contractor to the Company or an Affiliate. 
  
 1.13 “Employee” means any person that the Committee determines to be an employee of the
Company or an Affiliate. 
  

 1.14 “Exercise Price” means the price per Share at which an Option may
be exercised. 
  
 1.15 “Fair Market
Value” means an amount equal to the then fair market value of a Share as determined by the Committee pursuant to a reasonable method adopted in good faith for such purpose. Unless the Committee determines otherwise, if the Common Stock is
traded on a securities exchange or automated dealer quotation system, fair market value shall be the last sale price for a Share, as of the relevant date, on such securities exchange or automated dealer quotation system as reported by such source as
the Committee may select. 
  
 1.16
“Incentive Stock Option” means an Option granted under this Plan that the Committee designates as an incentive stock option under Section 422 of the Code. 
  
 1.17 “Non-Employee Director” means any member of the Company’s or an Affiliate’s
Board of Directors who is not an Employee. 
  
 1.18 “Nonqualified Stock Option” means an Option granted under this Plan that is not an Incentive Stock Option. 
  
 1.19 “Option” means an option to purchase Shares granted under this Plan in accordance with the terms of Section 6.

  
 1.20 “Option Period” means
the period during which an Option may be exercised. 
  
 1.21 “Other Stock-Based Award” means an Other Stock Based Award as defined in Section 13. 
  
 1.22 “Participant” means an Eligible Person who has been granted an Award hereunder. 
  
 1.23 “Performance Award” means a
performance award granted under this Plan in accordance with the terms of Section 11. 
  
 1.24 “Performance Goals” means performance goals that the Committee establishes, which may be based on: 
  
 (a) accounts receivable targets; 
  
 (b) satisfactory internal or external audits; 
  
 (c) achievement of balance sheet or income statement
objectives; 
  
 (d) cash flow (including
operating cash flow and free cash flow); 
  
 (e)
customer satisfaction metrics and achievement of customer satisfaction goals; 
  
 (f) dividend payments; 
  
 (g) earnings (including before or after taxes, interest, depreciation, and amortization); 
  
 (h) earnings growth; 
  
 (i) earnings per share; 
  
 (j) economic value added; 
  
 (k) expenses; 
  
 (l) improvement of financial ratings; 
  
 (m) internal rate of return; 
  
 (n) market share; 
  
 (o) net asset value; 
  
 (p) net income; 
  

 B-2 

 (q) net operating gross margin; 
  
 (r) net operating profit after taxes (“NOPAT”);

  
 (s) net sales growth; 
  
 (t) NOPAT growth; 
  
 (u) operating income; 
  
 (v) operating margin; 
  
 (w) comparisons to the performance of other companies;

  
 (x) pro forma income; 
  
 (y) regulatory compliance; 
  
 (z) return measures (including return on assets, designated
assets, capital, committed capital, net capital employed, equity, sales, or stockholder equity, and return versus the Company’s cost of capital); 
  
 (aa) revenues; 
  
 (bb) sales; 
  
 (cc) stock price (including growth measures and total stockholder return); 
  
 (dd) comparison to stock market indices; 
  
 (ee) implementation or completion of one or more projects or transactions; 
  
 (ff) working capital; or 
  
 (gg) any other objective goals that the Committee
establishes. 
  
 Performance Goals may be absolute in their terms
or measured against or in relationship to other companies comparably, similarly or otherwise situated. Performance Goals may be particular to an Eligible Person or the department, branch, Affiliate, or division in which the Eligible Person works, or
may be based on the performance of the Company, one or more Affiliates, or the Company and one or more Affiliates, and may cover such period as the Committee may specify. 
  
 1.25 “Plan” means this Yellow Roadway Corporation 2004 Long-Term Incentive and Equity Award
Plan, as amended from time to time. 
  
 1.26
“Related Option” means an Option in connection with which, or by amendment to which, a SAR is granted. 
  
 1.27 “Related SAR” means a SAR granted in connection with, or by amendment to, an Option. 
  
 1.28 “Restricted Stock” means Shares
granted under this Plan pursuant to the provisions of Section 9. 
  
 1.29 “Restricted Stock Units” means an award providing for the contingent grant of Shares (or the cash equivalent thereof) pursuant to the provisions of Section 10. 
  
 1.30 “SAR” means a stock appreciation right
granted under this Plan in accordance with the terms of Section 7. 
  
 1.31 “Section 422 Employee” means an Employee who is employed by the Company or a “parent corporation” or “subsidiary corporation” (both as defined in Sections 424(e) and (f) of
the Code) with respect to the Company. 
  
 1.32
“Share” means a share of Common Stock. 
  

 B-3 

 1.33 “Ten-Percent Stockholder” means a Section 422 Employee who
(applying the rules of Section 424(d) of the Code) owns stock possessing more than ten percent of the total combined voting power of all classes of stock of the Company or a “parent corporation” or “subsidiary corporation” (both
as defined in Sections 424(e) and (f) of the Code) with respect to the Company. 
  
 1.34 Construction. Unless the context expressly requires the contrary, references in this Plan to (a) the term “Section”
refers to the sections of this Plan, and (b) the word “including” means “including (without limitation).” 
  
 2. Purpose. This Plan is intended to assist the Company and its Affiliates in attracting and retaining Eligible Persons of
outstanding ability and to promote the identification of their interests with those of the stockholders of the Company and its Affiliates. 
  
 3. Administration. The Committee shall administer this Plan and shall have plenary authority, in its discretion, to grant Awards to
Eligible Persons, subject to the provisions of this Plan. The Committee shall have plenary authority and discretion, subject to the provisions of this Plan, to determine the Eligible Persons to whom it grants Awards, the terms (which terms need not
be identical) of all Awards, including the Exercise Price of Options, the time or times at which Awards are granted, the number of Shares covered by Awards, whether an Option shall be an Incentive Stock Option or a Nonqualified Stock Option, any
exceptions to nontransferability, and any Performance Goals applicable to Awards. In making these determinations, the Committee may take into account the nature of the services rendered or to be rendered by Award recipients, their present and
potential contributions to the success of the Company and its Affiliates, and such other factors as the Committee in its discretion shall deem relevant. Subject to the provisions of this Plan, the Committee shall have plenary authority to interpret
this Plan and Agreements, prescribe, amend and rescind rules and regulations relating to them, and make all other determinations deemed necessary or advisable for the administration of this Plan and Awards granted hereunder. The determinations of
the Committee on the matters referred to in this Section 3 shall be binding and final. The Committee may delegate its authority under this Section 3 and the terms of this Plan to such extent it deems desirable and is consistent with the requirements
of applicable law. 
  
 4. Eligibility. Awards
may be granted only to Eligible Persons. 
  
 5. Stock
Subject to Plan. 
  
 5.1 Number
of Shares. Subject to adjustment as provided in Section 14, the maximum number of Shares that may be issued under this Plan is 3.0 million Shares, plus (a) the number of Shares (not to exceed 0.43 million shares) authorized but not issued under
the Yellow Corporation Directors’ Stock Compensation Plan, the Yellow Corporation 2002 Stock Option and Share Award Plan, or the Yellow Corporation 1999 Stock Option Plan and (b) the number of Shares, if any, delivered to the Company as payment
of the Exercise Price of Options. Shares issued under this Plan may, in whole or in part, be authorized but unissued Shares or Shares that shall have been, or may be, reacquired by the Company in the open market, in private transactions or
otherwise. The number of Shares authorized for issuance under this Plan shall be decreased by two Shares for each Share issued pursuant to Awards that are Restricted Stock, Restricted Stock Units, Performance Awards or Other Stock-Based Awards (any
of the foregoing Awards are “Full Value Awards”). 
  
 5.2 Maximum Grant. Subject to adjustment as provided in Section 14, the maximum number of Shares with respect to which an Employee may be granted Awards under this Plan during any calendar year is 1.0 million
Shares. The maximum number of Shares with respect to which an Employee has been granted Awards shall be determined in accordance with Section 162(m) of the Code. 
  
 5.3 Adjustments to Number of Shares. If shares of Restricted Stock are forfeited or if an Award
(including a Full Value Award) otherwise terminates, expires, or is settled without all or a portion of the Shares covered by the Award being issued (including Shares not issued in order to satisfy withholding taxes), the forfeited or unissued
Shares under the terminated, expired, or settled Award shall again be available for the grant of Awards under this Plan. In the case of Full Value Awards, the number of Shares that again become available for the grant of Awards under this Plan shall
reflect the last sentence of Section 5.1, so that, by way of example, if ten shares of Restricted Stock are forfeited, twenty Shares shall again be available for the grant of Awards, subject to the last sentence of Section 5.1. 
  

 B-4 

 6. Options. 
  
 6.1 Types of Option Grants. Options granted under this Plan shall be either Incentive Stock Options
or Nonqualified Stock Options, as the Committee designates; provided, that Incentive Stock Options may only be granted to Eligible Persons who are Section 422 Employees on the Date of Grant. Each Option granted under this Plan shall be identified
either as a Nonqualified Stock Option or an Incentive Stock Option, and each Option shall be evidenced by an Agreement that specifies the terms and conditions of the Option. Options shall be subject to the terms and conditions set forth in this
Section 6 and such other terms and conditions not inconsistent with this Plan as the Committee may specify. The Committee may, in its discretion, condition the grant or vesting of an Option upon the achievement of one or more specified Performance
Goals. 
  
 6.2 Exercise Price. The
Exercise Price of an Option granted under this Plan shall not be less than 100% of the Fair Market Value of the Common Stock on the Date of Grant. Notwithstanding the foregoing, in the case of an Incentive Stock Option granted to an Employee who, on
the Date of Grant is a Ten-Percent Shareholder, the Exercise Price shall not be less than 110% of the Fair Market Value of a Share on the Date of Grant. 
  
 6.3 Option Exercise Period. The Committee shall determine the Option Period for an Option, which shall be specifically set forth in
the Agreement; provided, that an Option shall not be exercisable after ten years (five years in the case of an Incentive Stock Option granted to a Ten-Percent Stockholder) from its Date of Grant. 
  
 6.4 Surrender of Option. The Participant shall have
the right to surrender to the Company an Option (or a portion thereof) that has become exercisable and to receive upon the surrender, without any payment to the Company (other than required tax withholding amounts paid in accordance with Section 20)
that number of Shares (equal to the highest whole number of Shares) having an aggregate Fair Market Value as of the date of surrender equal to that number of Shares subject to the Option (or portion thereof) being surrendered multiplied by an amount
equal to the excess of (a) the Fair Market Value on the date of surrender, over (b) the Exercise Price, plus an amount of cash equal to the fair market value of any fractional Share to which the Participant would be entitled but for the
parenthetical above relating to whole number of Shares. 
  
 7. SARs. 
  
 7.1
Terms and Conditions of SAR. A SAR granted under this Plan shall be evidenced by an Agreement specifying the terms and conditions of the Award. 
  
 7.2 Grant of SAR. A SAR may be granted under this Plan: 
  
 (a) in connection with, and at the same time as, the grant of an Option under this Plan; 
  
 (b) by amendment of an outstanding Option granted under this
Plan; or 
  
 (c) independently of any Option
granted under this Plan. 
  
 A SAR described in clause (a) or (b)
of the preceding sentence is a Related SAR. A Related SAR may, in the Committee’s discretion, apply to all or any portion of the Shares subject to the Related Option. 
  
 7.3 Exercise of SAR. A SAR may be exercised in whole or in part as provided in the applicable
Agreement. Subject to the terms of the Agreement, a SAR entitles a Participant to receive, upon exercise and without payment to the Company (but subject to required tax withholding), either cash or that number of Shares (equal to the highest whole
number of Shares), or a combination thereof, in an amount or having an aggregate Fair Market Value as of the Date of Exercise not to exceed the number of Shares subject to the portion of the SAR exercised multiplied by an amount equal to the excess
of: 
  
 (a) the Fair Market Value on the Date of
Exercise of the SAR; over 
  
 (b) either (i) the
Fair Market Value on the Date of Grant (or such amount in excess of the Fair Market Value as the Committee may specify) of the SAR if it is not a Related SAR, or (ii) the Exercise Price as provided in the Related Option if the SAR is a Related SAR.

  
 7.4 SAR Exercise Period. The Committee
shall determine the period during which a SAR may be exercised, which period shall be specifically set forth in the Agreement; provided, that: 
  
 (a) a SAR will expire no later than the earlier of (i) ten years from the Date of Grant, or (ii) in the case of a Related SAR, the
expiration of the Related Option; and 
  

 B-5 

 (b) a Related SAR that is related to an Incentive Stock Option may be exercised only when
and to the extent the Related Option is exercisable. 
  
 7.5 Share Adjustment with Related SAR or Related Option. The exercise, in whole or in part, of a Related SAR shall cause a reduction in the number of Shares subject to the Related Option equal to the number of Shares with respect to
which the Related SAR is exercised. The exercise, in whole or in part, of a Related Option shall cause a reduction in the number of Shares subject to the Related SAR equal to the number of Shares with respect to which the Related Option is
exercised. 
  
 8. Exercise of Options and
SARs. 
  
 8.1 Methods of
Exercise. An Option or SAR may be exercised, in whole or in part and subject to the terms of the applicable Agreement evidencing the Award, by the Participant’s delivering to the Company a notice of the exercise, in such form as the
Committee may prescribe, accompanied, in the case of an Option, by: 
  
 (a) the Participant’s full payment for the Shares with respect to which the Option is exercised; or 
  
 (b) to the extent provided in the applicable Agreement or otherwise authorized by the Committee, 
  
 (i) for Participants other than the Company’s
designated executive officers and directors, payment may be effected by irrevocable instructions to a broker to deliver promptly to the Company cash equal to the exercise price of the Option (a broker-assisted cashless exercise); or 
  
 (ii) payment may be made by delivery (including
constructive delivery) of unencumbered Shares (provided that if the Shares were acquired pursuant to another option or other award granted under this Plan or under any other compensation plan maintained by the Company or any Affiliate, the Shares
shall have been held for such period, if any, as the Committee may specify) valued at Fair Market Value on the Date of Exercise. 
  
 9. Restricted Stock Awards. Each grant of Restricted Stock under this Plan shall be subject to an Agreement, stock certificate
transfer legend, or stop transfer instructions to the Company’s stock transfer agent, specifying the terms and conditions of the Award. Restricted Stock granted under this Plan shall consist of Shares that are restricted as to transfer, subject
to forfeiture, and subject to such other terms and conditions as the Committee may specify. The terms and conditions may provide, in the discretion of the Committee, for the lapse of transfer restrictions or forfeiture provisions to be accelerated
or contingent upon the achievement of one or more specified Performance Goals. 
  
 10. Restricted Stock Unit Awards. Each grant of Restricted Stock Units under this Plan shall be evidenced by an Agreement that (a) provides for the issuance of Shares to a Participant at such
time(s) as the Committee may specify, and (b) contains such other terms and conditions as the Committee may specify, including terms that condition the issuance of Shares upon the achievement of one or more specified Performance Goals. 

 
 11. Performance Awards. Each Performance Award
granted under this Plan shall be evidenced by an Agreement that (a) provides for the payment of cash or issuance of Shares, Options, or SARs contingent upon the attainment of one or more specified Performance Goals over such period as the Committee
may specify, and (b) contains such other terms and conditions as the Committee may specify. For purposes of Section 5.2, a Performance Award shall be deemed to cover a number of Shares equal to the maximum number of Shares that may be issued upon
payment of the Award. The maximum cash amount payable to any Employee pursuant to all Performance Awards granted to an Employee during a calendar year shall not exceed $5 million. 
  
 12. Dividends and Dividend Equivalents. The terms of an Award may, subject to such terms and conditions
as the Committee may specify, provide a Participant with the right to receive dividend payments or dividend equivalent payments with respect to Shares covered by the Award, which payments may be either made currently or credited to an account
established for the Participant, and may be settled in cash or Shares, as determined by the Committee. 
  
 13. Other Stock-Based Awards. The Committee may in its discretion grant stock-based awards of a type other than those otherwise
provided for in this Plan, including the issuance or offer for sale of unrestricted Shares (“Other Stock-Based Awards”). Other Stock-Based Awards shall cover such number of Shares and have such terms and conditions as the Committee shall
determine, including terms that condition the payment or vesting the Other Stock-Based Award upon the achievement of one or more Performance Goals. 
  

 B-6 

 14. Capital Events and Adjustments. 
  
 14.1 Automatic Adjustments. Unless otherwise
determined by the Committee on or prior to the date of an Automatic Adjustment Event, upon the occurrence of an Automatic Adjustment Event, each of the following shall, automatically and without need for Committee action, be proportionately
adjusted: 
  
 (a) the number of Shares subject to
outstanding Awards; 
  
 (b) the per Share
Exercise Price of Options and the per Share base price upon which payments under SARs that are not Related SARs are determined; 
  
 (c) the aggregate number Shares as to which Awards thereafter may be granted under this Plan; and 
  
 (d) the maximum number of Shares with respect to which an
Employee may be granted Awards during any calendar year. 
  
 14.2 Discretionary Adjustments. Subject to Section 14.1, in the event of any change in the outstanding Common Stock by reason of a stock dividend, stock split, reverse stock split, spin-off, recapitalization,
reclassification, combination or exchange of shares, merger, consolidation, liquidation or the like, the Committee may, as it deems equitable in its discretion, provide for a substitution for or adjustment in: 
  
 (a) the number and class of securities subject to
outstanding Awards or the type of consideration to be received upon the exercise or vesting of outstanding Awards; 
  
 (b) the Exercise Price of Options and the base price upon which payments under SARs that are not Related SARs are determined; 

 
 (c) the aggregate number and class of securities for
which Awards thereafter may be granted under this Plan; and 
  
 (d) the maximum number of securities with respect to which an Employee may be granted Awards during any calendar year. 
  
 Any provision of this Plan or any Agreement to the contrary notwithstanding, in the event of a merger or consolidation to which the Company is a party,
the Committee shall take such actions, if any, as it deems necessary or appropriate to prevent the enlargement or diminishment of Participants’ rights under this Plan and Awards granted hereunder, and may, in its discretion, cause any Award
granted hereunder to be canceled in consideration of a cash payment equal to the fair value of the canceled Award, as the Committee determines in its discretion. 
  
 15. Deferrals. The Committee may permit or require a Participant to defer the Participant’s
receipt of Shares or cash that would otherwise be due to the Participant pursuant to the terms of an Award upon such terms and conditions as the Committee may establish. 
  
 16. Termination or Amendment. The Board may amend or terminate this Plan in any respect at any time;
provided, that after the stockholders of the Company have approved this Plan, the Board shall not amend or terminate this Plan without approval of (a) the Company’s stockholders to the extent applicable law or regulations or the requirements of
the principal exchange or interdealer quotation system on which the Common Stock is listed or quoted, if any, requires stockholder approval of the amendment, and (b) each affected Participant if the amendment or termination would adversely affect
the Participant’s rights or obligations under any Award granted prior to the date of the amendment or termination. 
  
 17. Modification, Substitution of Awards. 
  
 17.1 Modification of Awards; No Reduction in Exercise Price. Subject to the terms and conditions of
this Plan, the Committee may modify the terms of any outstanding Awards; provided, that (a) no modification of an Award shall, without the consent of the Participant, alter or impair any of the Participant’s rights or obligations under the
Award, and (b) subject to Section 14, in no event may (i) an Option be modified to reduce the Exercise Price of the Option, (ii) a SAR be modified to reduce the applicable Exercise Price (in the case of a Related SAR) or base price (in the case of
other SARs), or (iii) an Option or SAR be cancelled or surrendered in consideration for the grant of a new Option or SAR with a lower Exercise Price or base price. 
  
 17.2 Substitution of Awards. Anything contained herein to the contrary notwithstanding, Awards may,
in the Committee’s discretion, be granted under this Plan in substitution for stock options and other awards covering capital stock of another 

  

 B-7 

 
corporation which is merged into, consolidated with, or all or a substantial portion of the property or stock of which is acquired by, the Company or one of
its Affiliates. The terms and conditions of the substitute Awards so granted may vary from the terms and conditions set forth in this Plan to such extent as the Committee may deem appropriate to conform, in whole or part, to the provisions of the
awards in substitution for which they are granted. Substitute Awards granted hereunder shall not be counted toward the Share limit imposed by Section 5.2, except to the extent the Committee determines that counting those Awards is required for
Awards granted hereunder to be eligible to qualify as “performance-based compensation” within the meaning of Section 162(m) of the Code. 
  
 18. Foreign Employees. Without amendment of this Plan, the Committee may grant Awards to Eligible Persons who are subject to the laws
of foreign countries or jurisdictions on such terms and conditions different from those specified in this Plan as may in the judgment of the Committee be necessary or desirable to foster and promote achievement of the purposes of this Plan. The
Committee may make such modifications, amendments, procedures, sub-plans and the like as may be necessary or advisable to comply with provisions of laws of other countries or jurisdictions in which the Company or any of its Affiliates operates or
has employees. 
  
 19. Stockholder Approval.
This Plan and any amendments to the Plan requiring stockholder approval pursuant to Section 16 are subject to approval by vote of the stockholders of the Company at the next annual or special meeting of stockholders following adoption by the Board.

  
 20. Withholding. The Company’s
obligation to issue or deliver Shares or pay any amount pursuant to the terms of any Award granted hereunder shall be subject to satisfaction of applicable federal, state, local and foreign tax withholding requirements. In accordance with such rules
as the Committee may prescribe, a Participant may satisfy any withholding tax requirements by one or any combination of the following means: 
  
 (a) tendering a cash payment; 
  
 (b) authorizing the Company to withhold Shares otherwise issuable to the Participant; or 
  
 (c) delivering to the Company already-owned and unencumbered
Shares. 
  
 21. No Loans. Notwithstanding any
other provision of this Plan to the contrary, no loans will be permitted by the Company to the Company’s designated executive officers and directors, including without limitation a loan in conjunction with the exercise of an Option or SAR and a
transaction structured as a broker-assisted cashless exercise. 
  
 22. Term of Plan. Unless the Board terminates this Plan pursuant to Section 16 on an earlier date, this Plan shall terminate on the date that is ten years after the earlier of that date that the Board adopts this Plan
or the Company’s stockholders approve this Plan, and no Awards may be granted after that date. The termination of this Plan shall not affect the validity of any Award outstanding on the date of termination. 
  
 23. Indemnification of Committee. In addition to such
other rights of indemnification as they may have as members of the Board or Committee, the Company shall indemnify members of the Committee against all reasonable expenses, including attorneys’ fees, actually and reasonably incurred in
connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with this Plan or any Award
granted hereunder, and against all amounts reasonably paid by them in settlement thereof or paid by them in satisfaction of a judgment in any such action, suit or proceeding, if those members acted in good faith and in a manner which they believed
to be in, and not opposed to, the best interests of the Company. 
  
 24. General Provisions. 
  
 24.1 No Legal or Equitable Rights Conferred. The establishment of this Plan shall not confer upon any Eligible Person any legal or equitable right against the Company, any Affiliate or the Committee, except as
expressly provided in this Plan. Participation in this Plan shall not give an Eligible Person any right to be retained in the service of the Company or any Affiliate. 
  
 24.2 Power of Company to Issue Awards or Adopt Other Plans. Neither the adoption of this Plan nor its
submission to the Company’s stockholders shall be taken to impose any limitations on the powers of the Company or its Affiliates to issue, grant, or assume options, warrants, rights, or restricted stock, or other awards otherwise than under
this Plan, or to adopt other stock option, restricted stock, or other plans, or to impose any requirement of stockholder approval upon the same. 
  
 24.3 Non-Transferability of Awards. The interests of any Eligible Person under this Plan or Awards granted hereunder are not
subject to the claims of creditors and may not, in any way, be transferred, assigned, alienated or encumbered, except to the extent provided in an Agreement. 
  

 B-8 

 24.4 Governing Law. This Plan shall be governed, construed and administered in
accordance with the laws of the State of Delaware without giving effect to the conflict of laws principles. 
  
 24.5 Award Restrictions. The Committee may require each person acquiring Shares pursuant to Awards granted hereunder to represent
to and agree with the Company in writing that the person is acquiring the Shares without a view to distribution thereof. The certificates for the Shares may include any legend which the Committee deems appropriate to reflect any restrictions on
transfer. All certificates for Shares issued pursuant to this Plan shall be subject to such stock transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations, and other requirements of the Securities and
Exchange Commission, any stock exchange upon which the Common Stock is then listed or interdealer quotation system upon which the Common Stock is then quoted, and any applicable federal or state securities laws. The Committee may place a legend or
legends on certificates for Shares to make appropriate reference to the restrictions. 
  
 24.6 Regulatory Approvals and Compliance with Securities Laws. The Company shall not be required to issue any certificate or
certificates for Shares with respect to Awards granted under this Plan, or record any person as a holder of record of Shares, without obtaining, to the complete satisfaction of the Committee, the approval of all regulatory bodies the Committee deems
necessary, and without complying to the Board’s or Committee’s complete satisfaction, with all rules and regulations, under federal, state or local law the Committee deems applicable. 
  
 24.7 Non-certificated Awards; No Fractional Shares.
To the extent that this Plan provides for issuance of stock certificates to reflect the issuance of Shares, the issuance may be effected on a non-certificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange
or automated dealer quotation system on which the Shares are traded. No fractional Shares shall be issued or delivered pursuant to this Plan or any award. The Committee shall determine whether cash, other Awards, or other property shall be issued or
paid in lieu of any fractional Shares or whether any fractional Shares or any rights thereto shall be forfeited or otherwise eliminated. 
  

 B-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]